Abeona Therapeutics (ABEO) Current Assets (2010 - 2026)

Abeona Therapeutics' Current Assets history runs 17 years deep, the most recent figure standing at $183.0 million for Q1 2026.

• In Q1 2026, Current Assets rose 107.65% year-over-year to $183.0 million; the TTM figure through Mar 2026 stood at $183.0 million (up 107.65% YoY), while the FY2025 annual figure was $204.9 million, up 103.17% from the prior year.
• Current Assets for Q1 2026 stood at $183.0 million, down from $204.9 million in the prior quarter.
• The five-year high for Current Assets was $232.3 million in Q2 2025, with the low at $25.5 million in Q3 2022.
• The 5-year median for Current Assets is $66.7 million (2024), against an average of $98.7 million.
• The sharpest annual moves came in 2022 and 2024: Current Assets plunged 62.45% in 2022, then soared 185.9% in 2024.
• Abeona Therapeutics' Current Assets stood at $53.1 million in 2022, then rose by 4.97% to $55.7 million in 2023, then soared by 80.94% to $100.9 million in 2024, then jumped by 103.17% to $204.9 million in 2025, then declined by 10.7% to $183.0 million in 2026.
• Business Quant data shows ABEO's Current Assets at $183.0 million in Q1 2026, $204.9 million in Q4 2025, and $216.1 million in Q3 2025.